Agilvax

Agilvax

Agilvax

Private company working to discover and develop immunotherapies to combat cancer and targeted vaccines against infectious diseases. Currently focusing on TNBC
Follow us
Alexa global traffic share
Twitter followers
Latest funding
Undisclosed amount
Venture capital (Series A) - 2018
Sun Mountain Capital Hunt Holdings LP
Team Size
1–10
Employees
Venture capital (Series A)
FinSMEs

Agilvax Closes Undisclosed Series A1 Financing

Health Funding